⌘K
Loading ticker…
Supernus Pharmaceuticals, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Supernus Pharmaceuticals, Inc. (SUPN) has a 3-month relative strength percentile of 28 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.2%, relative volume 5.22×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
28 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
SUPN is in a stage 3 topping pattern, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -1.5% / -4.4%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
SUPN is held by 9 ETFs as of Mar 2026. Top owner: IJR at 0.19% weight, $178M notional. Top 3 carry $337M.
Top 9 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.19% | $178M |
| VTIVanguard Total Stock Market ETF | 0.00% | $90M |
| IWMiShares Russell 2000 ETF | 0.10% | $70M |
| VBVanguard Small Cap ETF | 0.04% | $65M |
| VBRVanguard Small Cap Value ETF | 0.07% | $41M |
| VXFVanguard Extended Market ETF | 0.04% | $33M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 1.86% | $6M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.01% | $4M |
| IWOiShares Russell 2000 Growth ETF | 0.02% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SUPN Jan avg: 3.41% median: 1.51% win: 50% σ: 9.01% n: 4 2022-04-12 → 2026-05-29 | SUPN Feb avg: -0.96% median: -0.52% win: 50% σ: 13.85% n: 4 2022-04-12 → 2026-05-29 | SUPN Mar avg: 1.96% median: -0.73% win: 50% σ: 9.20% n: 4 2022-04-12 → 2026-05-29 | SUPN Apr avg: -6.07% median: -7.14% win: 20% σ: 6.36% n: 5 2022-04-12 → 2026-05-29 | SUPN May avg: -5.26% median: -3.79% win: 0% σ: 4.52% n: 5 2022-04-12 → 2026-05-29 | SUPN Jun avg: -1.86% median: -0.97% win: 25% σ: 5.44% n: 4 2022-04-12 → 2026-05-29 (current) | SUPN Jul avg: 8.68% median: 10.57% win: 100% σ: 4.46% n: 4 2022-04-12 → 2026-05-29 | SUPN Aug avg: 14.50% median: 12.86% win: 100% σ: 11.09% n: 4 2022-04-12 → 2026-05-29 | SUPN Sep avg: -4.98% median: -6.21% win: 25% σ: 9.04% n: 4 2022-04-12 → 2026-05-29 | SUPN Oct avg: 3.09% median: 5.25% win: 75% σ: 12.48% n: 4 2022-04-12 → 2026-05-29 | SUPN Nov avg: 2.86% median: 7.24% win: 75% σ: 13.84% n: 4 2022-04-12 → 2026-05-29 | SUPN Dec avg: 2.81% median: 2.54% win: 50% σ: 5.70% n: 4 2022-04-12 → 2026-05-29 |